Home and
 

Keywords :   


Tag: and

Study finds 3D printing of metal parts could reduce an airplanes weight by 4-7%; fuel, CO2 and metal savings

2015-06-03 13:55:33| Green Car Congress

Tags: and study parts weight

 

W. L. Gore & Associates, Inc. - Medical Equipment - Deals and...

2015-06-01 04:39:51| Industrial Machines - Topix.net

L. Gore & Associates, Inc. - Medical Equipment - Deals and Alliances Profile", is now available at Fast Market Research W. L. Gore & Associates, Inc. carries out the manufacture and marketing of fluoro-polymer products for the medical, electronics, nuclear, fabrics and industrial markets. The company's medical division provides surgeons and patients a variety of surgical products and medical OEM products.

Tags: and equipment medical deals

 
 

Barges and jobs; a callous crowd: Editorial peaks and valleys

2015-05-30 00:48:02| Appliances - Topix.net

On Saturday, Gunderson will launch a 578-foot-long barge capable of carrying up to 185,000 barrels of oil or chemicals. The job employed more than 200 people.

Tags: and jobs editorial crowd

 

15/07/2015 to 15/07/2015 - BIM Workshop presented by BIFM and FutureFit

2015-05-29 16:47:14| BIFM Events

FutureFit Built Assets European project and BIFM have teamed up to host an introductory workshop about BIM in facilities management.

Tags: and presented workshop bim

 

Merck Submits U.S. New Drug Application for Grazoprevir/Elbasvir, an Investigational Once-Daily, Single Tablet Combination Therapy, for Treatment of Chronic Hepatitis C Genotypes 1, 4, and 6 Infection

2015-05-28 22:30:00| Merck.com - Research & Development News

Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for grazoprevir/elbasvir (100mg/50mg), an investigational once-daily, single tablet combination therapy for the treatment of adult patients with chronic hepatitis C genotypes (GT) 1, 4 or 6 infection. Within 60 days of submission, the FDA will determine whether it will accept for review Merck's application as filed. Language: English Contact: MerckMedia:Doris Li, 908-246-5701orSarra Herzog, 908-740-1871orInvestors:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: and single application treatment

 

Sites : [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] next »